Publications by authors named "Arwa S Alabide"
Article Synopsis
- - Resmetirom, a selective thyroid hormone receptor-β agonist, shows potential in treating non-alcoholic steatohepatitis (NASH), a major cause of liver-related health issues globally.
- - A systematic review and meta-analysis indicated that Resmetirom significantly reduced low-density lipoprotein cholesterol (LDL-C) and alanine aminotransferase (ALT) levels compared to a placebo, although it also increased the risk of side effects like diarrhea and nausea.
- - Overall, Resmetirom appears to be a promising option for improving liver health in NASH patients, potentially filling a gap in current treatment strategies.
Introduction: Infarction of the artery of Percheron (AOP) is a rare vascular condition where a single arterial branch supplies blood to the thalamic and midbrain regions, leading to neurological deficits. The challenge lies in its often-delayed diagnosis due to its rarity and diverse clinical presentations, necessitating heightened awareness among clinicians for expedited diagnosis and appropriate therapeutic interventions.
Materials And Methods: All relevant studies involving patients diagnosed with infarction of AOP were retrieved from PubMed, Google Scholar, Web of Science, and Scopus.